Literature DB >> 17014880

Potential of ancestral sylvatic dengue-2 viruses to re-emerge.

Nikos Vasilakis1, Elisabeth J Shell, Eric B Fokam, Peter W Mason, Kathryn A Hanley, D Mark Estes, Scott C Weaver.   

Abstract

Dengue viruses (DENV) are the most important arboviral pathogens in tropical and subtropical regions throughout the world. DENV transmission includes both a sylvatic, enzootic cycle between nonhuman primates and arboreal mosquitoes of the genus Aedes, and an urban, endemic/epidemic cycle between Aedes aegypti, a mosquito with larval development in peridomestic water containers, and human reservoir hosts. All 4 serotypes of endemic DENV evolved independently from ancestral sylvatic viruses and have become both ecologically and evolutionarily distinct; this process may have involved adaptation to (i) peridomestic mosquito vectors and/or (ii) human reservoir hosts. To test the latter hypothesis, we assessed the ability of sylvatic and endemic DENV-2 strains, representing major genotypes from Southeast Asia, West Africa and the Americas, to replicate in two surrogate human model hosts: monocyte-derived, human dendritic cells (moDCs), and mice engrafted with human hepatoma cells. Although the various DENV-2 strains showed significant inter-strain variation in mean replication titers in both models, no overall difference between sylvatic and endemic strains was detected in either model. Our findings suggest that emergence of endemic DENV strains from ancestral sylvatic strains may not have required adaptation to replicate more efficiently in human reservoir hosts, implying that the potential for re-emergence of sylvatic dengue strains into the endemic cycle is high. The shared replication profiles of the American endemic and sylvatic strains suggest that American strains have maintained or regained the ancestral phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014880      PMCID: PMC3608925          DOI: 10.1016/j.virol.2006.08.049

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  63 in total

1.  Genetic variation in the 3' non-coding region of dengue viruses.

Authors:  A C Shurtleff; D W Beasley; J J Chen; H Ni; M T Suderman; H Wang; R Xu; E Wang; S C Weaver; D M Watts; K L Russell; A D Barrett
Journal:  Virology       Date:  2001-03-01       Impact factor: 3.616

2.  Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.

Authors:  Lewis Markoff; Xiaou Pang; Huo-shu Houng Hs; Barry Falgout; Raymond Olsen; Estella Jones; Stephanie Polo
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses.

Authors:  E Wang; H Ni; R Xu; A D Barrett; S J Watowich; D J Gubler; S C Weaver
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever.

Authors:  D M Watts; K R Porter; P Putvatana; B Vasquez; C Calampa; C G Hayes; S B Halstead
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

5.  Development of a novel mouse model for dengue virus infection.

Authors:  J An; J Kimura-Kuroda; Y Hirabayashi; K Yasui
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

6.  Sylvatic transmission of arboviruses among Bornean orangutans.

Authors:  N D Wolfe; A M Kilbourn; W B Karesh; H A Rahman; E J Bosi; B C Cropp; M Andau; A Spielman; D J Gubler
Journal:  Am J Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.345

7.  Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis.

Authors:  A Couvelard; P Marianneau; C Bedel; M T Drouet; F Vachon; D Hénin; V Deubel
Journal:  Hum Pathol       Date:  1999-09       Impact factor: 3.466

8.  Dengue virus structural differences that correlate with pathogenesis.

Authors:  K C Leitmeyer; D W Vaughn; D M Watts; R Salas; I Villalobos; C Ramos; R Rico-Hesse
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  Human skin Langerhans cells are targets of dengue virus infection.

Authors:  S J Wu; G Grouard-Vogel; W Sun; J R Mascola; E Brachtel; R Putvatana; M K Louder; L Filgueira; M A Marovich; H K Wong; A Blauvelt; G S Murphy; M L Robb; B L Innes; D L Birx; C G Hayes; S S Frankel
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

10.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

View more
  48 in total

1.  Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins.

Authors:  Tomer Hertz; David Nolan; Ian James; Mina John; Silvana Gaudieri; Elizabeth Phillips; Jim C Huang; Gonzalo Riadi; Simon Mallal; Nebojsa Jojic
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

2.  Physiological and biochemical effects of botanical extract from Piper nigrum Linn (Piperaceae) against the dengue vector Aedes aegypti Liston (Diptera: Culicidae).

Authors:  Jalasteen Lija-Escaline; Sengottayan Senthil-Nathan; Annamalai Thanigaivel; Venkatraman Pradeepa; Prabhakaran Vasantha-Srinivasan; Athirstam Ponsankar; Edward Sam Edwin; Selvaraj Selin-Rani; Ahmed Abdel-Megeed
Journal:  Parasitol Res       Date:  2015-08-16       Impact factor: 2.289

3.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 4.  RNA virus genomics: a world of possibilities.

Authors:  Edward C Holmes
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

5.  Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses.

Authors:  Nikos Vasilakis; Jane Cardosa; Mawlouth Diallo; Amadou A Sall; Edward C Holmes; Kathryn A Hanley; Scott C Weaver; Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2010-04       Impact factor: 5.103

6.  Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.

Authors:  Kathryn A Hanley; Mathilde Guerbois; Tiffany F Kautz; Meredith Brown; Stephen S Whitehead; Scott C Weaver; Nikos Vasilakis; Preston A Marx
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

Review 7.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

8.  Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity.

Authors:  Anna P Durbin; Sandra V Mayer; Shannan L Rossi; Irma Y Amaya-Larios; Jose Ramos-Castaneda; Eng Eong Ooi; M Jane Cardosa; Jorge L Munoz-Jordan; Robert B Tesh; William B Messer; Scott C Weaver; Nikos Vasilakis
Journal:  Virology       Date:  2013-02-26       Impact factor: 3.616

9.  Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells.

Authors:  Nikos Vasilakis; Eleanor R Deardorff; Joan L Kenney; Shannan L Rossi; Kathryn A Hanley; Scott C Weaver
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

10.  Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever.

Authors:  Jane Cardosa; Mong How Ooi; Phaik Hooi Tio; David Perera; Edward C Holmes; Khatijar Bibi; Zahara Abdul Manap
Journal:  PLoS Negl Trop Dis       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.